Treace Medical Concepts Inc expected to post a loss of 29 cents a share - Earnings Preview

Treace Medical Concepts

05/11/2022 03:10

* Treace Medical Concepts Inc  TMCI.OQ   TMCI.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 8. 
    * The Ponte Vedra Florida-based  company is expected to
report  a
39.1% increase in revenue to $30.067 million from $21.62 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Treace Medical
Concepts
Inc is for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $28​, above​ its last closing price of $22.04.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.19       -0.20      -0.31     Missed  -51.2
 Mar. 31 2022  -0.21       -0.20      -0.16     Beat    21
 Dec. 31 2021  -0.01       0.00       -0.12     Missed  -2,300
                                                        ​
 Sep. 30 2021  -0.12       -0.12      -0.12     Met     0
 ​​Jun.        -0.12       -0.12      -0.10     Beat    16.7
 30 2021                                                
 Mar. 31 2021  -0.06       -0.06      -0.07     Missed  -16.7​
 This summary was machine generated November 5 at 03:09 GMT.  All
figures in US dollars  unless otherwise stated